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KEY POINTS
 Gastroesophageal reflux is a normal physiologic process that does not require treatment.
 In infants, reducing feeding volumes, offering smaller, more frequent meals, thickening
feeds, and positioning can reduce reflux episodes; these infants should not be placed
on acid suppression.
 Gastroesophageal reflux disease (GERD) occurs when reflux of gastric contents causes
troublesome symptoms or complications. First-line treatment in children and adolescents
includes lifestyle modification and acid suppression.
 GERD can have atypical presentations, such as recurrent pneumonia, upper airway symp-
toms, nocturnal or difficult to control asthma, dental erosions, and Sandifer syndrome.
 Diagnosis of GERD is largely based upon history and physical, but endoscopy and pH
impedance can be used to help support the diagnosis in atypical presentations.INTRODUCTION
Gastroesophageal reflux (GER) is a normal physiologic process. It is defined as the
involuntary flow of stomach content back into the esophagus.1 Most episodes of reflux
are into the distal esophagus, brief, and asymptomatic. GER disease (GERD) occurs
when reflux causes troublesome symptoms or complications.2
PHYSIOLOGY
Multiple mechanisms are in place to protect from reflux: the antireflux barrier,
esophageal clearance, and esophageal mucosal resistance. The antireflux barrier
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Downloaddiaphragm, and the phrenoesophageal ligament.3 The LES consists of tonically
contracted circular smooth muscles, composed of the intrinsic muscles of
the distal esophagus and the sling fibers of the proximal stomach.4 The crural dia-
phragm forms the esophageal hiatus and encircles the proximal LES. The phre-
noesophageal ligament anchors the distal esophagus to the crural diaphragm. A
small portion of the LES, up to 2 cm in adults, is intraabdominal. The LES resting
pressure is higher than the intraabdominal pressure, and this prevents reflux of
gastric contents into the distal esophagus. The angle of His is an acute angle
between the great curvature of the stomach and the esophagus, and acts as an
antireflux barrier by functioning like a valve. Esophageal clearance limits the
duration of contact between luminal contents and esophageal epithelium.1 Gravity
and esophageal peristalsis remove volume from the esophageal lumen, and sali-
vary and esophageal secretions neutralize acid. Esophageal mucosal resistance
comes into play when acid contact time is prolonged, and this is determined
genetically.
MECHANISMS OF GASTROESOPHAGEAL REFLUX
Anything that interferes with these lines of defense can lead to GER. Inappropriate
transient LES relaxation is among the most important causes of GERD in children.5,6
Increased intraabdominal pressure relative to LES resting pressure permits the reflux
of gastric contents into the distal esophagus.6 Increased intraabdominal pressure
can be caused by medications, the Valsalva maneuver, the Trendelenburg position,
or lifting. Position and posture influence the angle of His, with esophageal acid expo-
sure greater in the right side sleeping position than in the left position. Esophageal
clearance is also delayed in the right position.1 Although little is known about the
angle of His in infants, it is hypothesized that this angle is less acute in young infants
and becomes acute after 1 year of age; this would predispose their stomach to a
more vertical lie and therefore increased ease of reflux.1 In sliding hiatal hernias,
there is a weakness of the phrenoesophageal ligament leading to an upward
displacement of the LES into the lower mediastinum. As a result, the defense of
the LES, angle of His, and the diaphragm are compromised.3 The LES and crural dia-
phragm no longer overlap, and the LES length and pressure are reduced. Another
proposed mechanism by which hiatal hernia leads to GER is by creating a hernia
sac between the LES proximally and the crural diaphragm distally.7 This sac has
increased acid exposure and impaired clearance, and can reflux during subsequent
swallow relaxations of the LES.7
DISTINGUISHING GASTROESOPHAGEAL REFLUX FROM GASTROESOPHAGEAL REFLUX
DISEASE
Whereas GER is a normal physiologic process, GERD occurs when reflux of gastric
contents causes troublesome symptoms or complications.2 In infants, crying and
fussiness are often attributed to GERD, but are nonspecific and difficult to distin-
guish from other causes. GERD can cause infants to associate feeding with pain,
and as a result feeding aversion, anorexia, and failure to thrive can develop.2 Res-
piratory complications are less common, but recurrent pneumonia and interstitial
lung disease secondary to reflux can occur owing to aspiration of gastric contents.8
Reflux worsening asthma symptoms has also been reported.9,10 Histologic changes
can also help distinguish the two, with esophageal biopsies in GERD typically
showing findings of basal zone hyperplasia, papillary lengthening, and neutrophil
infiltration.11,12ed for Anonymous User (n/a) at Rady Childrens Hospital from ClinicalKey.com/nursing by Elsevier on September 10, 2018.
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DoEPIDEMIOLOGY
There are few pediatric-specific data on GER and GERD epidemiology with incidence
and prevalence based on questionnaires. The incidence of GERD in pediatrics was
estimated to be 0.84 per 1000 person-years.13 After 1 year of age, the incidence of
GERD decreases with until age 12, and then reaches a maximum at age 16 to 17.
The prevalence varies by study and age. It is estimated that 10% of all children
have GER14 and 1.8% to 8.2% have GERD.14,15 The estimated prevalence of GERD
in infants 0 to 23 months, children 2 to 11 years old, and adolescents 12 to 17 years
old is 2.2% to 12.6%, 0.6% to 4.1%, and 0.8% to 7.6%, respectively.
PRESENTING SYMPTOMS
Infancy
Daily regurgitation in healthy infants is physiologic and common, with the prevalence
being highest in the first 3 to 4 months of life, at between 41% and 73%.16–18 A large
proportion of these infants regurgitate more than 4 times a day. Prevalence de-
creases to 14% at 7 months of age,17 and to less than 5% after 12 months of
age.16,18 GERD can be difficult to diagnose in infants because they present with
nonspecific symptoms that can be difficult to distinguish from other conditions
(Box 1).19,20 These symptoms include choking, gagging, irritability, regurgitation,
refusal to feed, and poor weight gain. Crying, irritability, and vomiting are often attrib-
uted to GERD,18 but can be indistinguishable from milk protein allergy21,22 and do not
correlate well with reflux on pH impedance studies,23,24 or improve after trials of pro-
ton pump inhibitors (PPIs).25,26 A history and physical examination should be done to
rule out warning signals that require further investigation (Box 2),19 before attributing
them to GERD.
Childhood
GERD is often diagnosed in adults based on a history of substernal, burning pain, with
or without regurgitation.2 The diagnosis of GERD can similarly be made in adoles-
cents.27 However, history is unreliable in children under the age of 12, and these chil-
dren can also present with different symptoms. In addition to the aforementioned
typical GERD symptoms, 21% of children reported nausea or vomiting.13 Abdominal
pain and cough are also reported frequently.28 In children with erosive esophagitis,
cough, anorexia, and feeding refusal were found to be more frequent and severe in
children ages 1 to 5 years of age, as compared with older children, while heartburn
was less severe. Symptoms have not been found to be predictive of mucosal damage.
Children with certain underlying disorders are at high risk for developing severe and
chronic GERD (Table 1).19
Atypical Presentations
An association between asthma and reflux measured by pH or impedance has been
reported,29 although the etiology is not established. Proposed mechanisms of
GERD contributing to asthma include aspiration of gastric acid resulting in airway
inflammation and causing vagally mediated bronchial or laryngeal spasm.30 Alterna-
tively, asthma may contribute to GERD. Pulmonary hyperinflation occurs as a result
of chronic asthma. This hyperinflation causes the diaphragm to flatten, displacing
the LES into the thoracic cavity, which has a negative atmosphere pressure, and
thereby reduces the LES resting pressure and eliminates the angle of His. Studies
have shown that the majority of children with asthma have an abnormal pH impedance
study31; however, the use of a PPI in unselected patients with wheezing or asthma is ofwnloaded for Anonymous User (n/a) at Rady Childrens Hospital from ClinicalKey.com/nursing by Elsevier on September 10, 2018.
For personal use only. No other uses without permission. Copyright ©2018. Elsevier Inc. All rights reserved.
Box 1
Differential diagnosis for emesis is an infant or child
Gastrointestinal obstruction
 Esophageal web
 Esophageal stricture
 Tracheoesophageal fistula
 Pyloric stenosis
 Duodenal atresia
 Malrotation with intermittent volvulus
 Intestinal duplication
 Antral/duodenal web
 Hirschsprung disease
 Foreign body/bezoar
 Incarcerated hernia
 Imperforate anus
Other gastrointestinal disorders
 Celiac disease
 Milk/soy protein allergy
 Achalasia
 Gastroparesis
 Peptic ulcer
 Eosinophilic esophagitis/gastroenteritis
 Inflammatory bowel disease
 Appendicitis
 Pancreatitis
 Cholecystitis/choledocholithiasis
Neurologic
 Intracranial mass
 Hydrocephalus
 Subdural hematoma
 Intracranial hemorrhage
 Infant migraine
 Chiari malformation
Infectious
 Meningitis
 Gastroenteritis
 Sinusitis
 Urinary tract infection
 Pneumonia
 Otitis media
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 Hepatitis
 Sepsis
Metabolic/endocrine
 Galactosemia
 Hereditary fructosemia
 Urea cycle defects
 Amino and organic acidemias
 Fatty acid oxidation disorders
 Lysosomal storage disorders
 Congenital adrenal hyperplasia
 Diabetic ketoacidosis
Renal
 Obstructive uropathy
 Nephrolithiasis
 Renal tubular acidosis
 Renal insufficiency
Other
 Self-induced vomiting
 Cyclic vomiting syndrome
 Rumination
 Overfeeding
 Autonomic dysfunction
 Munchausen syndrome by proxy
 Medication/vitamin/drug toxicity
 Child abuse
Adapted from Vandeplas Y, Rudolph CD, Di Lorenzo C, et al. Pediatric gastroesophageal reflux
clinical practice guidelines: joint recommendations of the North American Society for Pediatric
Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pedi-
atric Gastroenterology, Hepatology, and Nutrition (ESPGHAN). J Pediatr Gastroenterol Nutr
2009;49(4):498–547; and Chandran L, Chitkara M. Vomiting in children: reassurance, red flag,
or referral? Pediatr Rev 2008;29(6):183–92.
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Dolimited benefit.32 Patients who may benefit from GERD treatment include those with
heartburn, nocturnal asthma symptoms, or steroid-dependent and difficult-to-
control asthma.9,10
Recurrent pneumonia and interstitial lung disease may be complications of GERD
owing to aspiration of gastric contents.8 Although an abnormal esophageal pH study
may increase the probability of GERD causing recurrent aspirations, there is no defin-
itive test that can prove GERD’s causal role.33
Upper airway symptoms attributed to GERD include hoarseness, chronic cough, or
a sensation of a lump in the throat,34 although there are no strong data to support this
claim.35 Laryngoscopic findings attributed to reflux include erythema, edema, cobble-
stoning, and nodularity, although with low sensitivity and specificity36,37 and poor cor-
relation with pH probe studies.38wnloaded for Anonymous User (n/a) at Rady Childrens Hospital from ClinicalKey.com/nursing by Elsevier on September 10, 2018.
For personal use only. No other uses without permission. Copyright ©2018. Elsevier Inc. All rights reserved.
Box 2
Warning signals that require investigation in infants with vomiting
Bilious emesis
Gastrointestinal bleeding: hematemesis, coffee ground emesis, hematochezia
Choking, gagging, coughing with feeds
Forceful emesis
Onset of emesis after 6 months of life
Failure to thrive
Diarrhea/constipation
Fever
Lethargy
Hepatosplenomegaly
Bulging fontanelle
Microcephaly or macrocephaly
Seizures
Abdominal tenderness or distention
Suspected genetic syndrome
Mousa & Hassan492
DownloadStudies revealedacauseandeffect relationshipbetweenGERDanddental erosions,39
with worse dental erosions when GERD symptoms are present. Other contributing fac-
tors to dental erosions include drinking juice, bulimia, racial and genetic factors affecting
the characteristic of enamel and saliva, and children with neurologic impairment.Table 1
Medical conditions at high risk for gastroesophageal reflux disease
Condition Contributing Factors
Neurologic impairment Decreased esophageal clearance
 Supine position
 Abnormal swallow
 Abnormal muscle tone
Increased reflux episodes
 Heightened gag reflex
 Delayed gastric emptying
 Constipation
 Skeletal abnormalities
 Medication side effects
Obesity
Esophageal atresia Esophagus is congenitally dysmotile
After surgery, a hiatal hernia is often present
Chronic respiratory disorders
 Bronchopulmonary dysplasia
 Cystic fibrosis
 Idiopathic interstitial fibrosis
Unknown
Lung transplantation Pneumonectomy contributes to esophageal and gastric
motor dysfunction
ed for Anonymous User (n/a) at Rady Childrens Hospital from ClinicalKey.com/nursing by Elsevier on September 10, 2018.
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DoSandifer syndrome, in which there is spasmodic torsional dystonia with arching of
the back and rigid opisthotonic posturing of the neck and back, is an uncommon
but specific presentation of GERD.2 It must be distinguished from seizures, dystonia,
or infantile spasms.40 When related to GERD, it improves with antireflux treatment.
An apparent life-threatening event (ALTE) was first defined in 1986 as an episode that
is frightening to the observer and that is characterized by some combination of apnea,
color change, marked change in muscle tone, choking, or gagging.41 The term ALTE
was recently replaced by the term “brief resolved unexplained event,” which is charac-
terized by a sudden, brief, and resolved episode occurring in an infant under 1 year of
age that consists of one ofmore of the following: cyanosis or pallor; absent, decreased,
or irregular breathing; marked change in tone; and altered level of responsiveness.
Because the change was recently made, published studies have evaluated GERD as-
sociation with the ALTE definition. The results are conflicting. Although most series fail
to demonstrate a temporal relationship between the two,29,42 multiple studies do show
that there is an association.43–45 If other causes have been ruled out and GER is sus-
pected, the diagnosis can be better evaluated by recording synchronous symptoms
on multichannel intraluminal impedance (MII)/pH esophageal monitoring in combina-
tion with cardiorespiratory monitoring. When using esophageal manometry in conjunc-
tion with cardiorespiratory monitoring, infants with ALTE were found to have
swallowing as the most frequent esophageal event associated with spontaneous res-
piratory events. This suggests a dysfunctional regulation of the swallow–respiratory in-
teractions, and needs to be investigated further.46 When using polysomnography with
esophageal pH and impedance monitoring, apnea was seldom associated with reflux.
When it was, the predominant sequence of events was obstructive or mixed apnea fol-
lowed by reflux, suggesting against reflux as a cause of apnea.47
Apnea and sleep quality have similarly been evaluated by a combination of poly-
somnography with esophageal pH and impedance monitoring. The data, again, are
conflicting. In some, GER was found unlikely to be related to apneic events and rarely
seemed to cause sleep awakening.48,49 Instead, awakening and arousal was precip-
itating GER. Another group has shown that acid and non–acid reflux was associated
with sleep interruption in infants,50 and acid reflux was associated with sleep interrup-
tion in obese children.51DIAGNOSIS
The diagnosis of GERD can largely be based on history and physical examination
alone. There are several tools, however, to help make the diagnosis when there is
an atypical presentation and to assess the severity and consequence of GERD.
Endoscopy
On endoscopy, visualizing endoscopic breaks in the mucosa is the most reliable evi-
dence of reflux esophagitis.19 The classic histologic findings of GERD are basal zone
hyperplasia, papillary lengthening, and neutrophilic infiltration.12 Although the histo-
logic findings are not specific to GERD alone and have not correlated well with symp-
tom severity of GERD in children,52 they can help to support the diagnosis. The
sensitivity of histology increases if multiple biopsies are taken, sampling in the mid
and distal esophagus.11,53 If using this method, the sensitivity of histology was 96%
in patients with erosive esophagitis and 76% with nonerosive reflux disease.53 The
additional usefulness of pursuing endoscopy includes ruling out other disorders that
can masquerade as GERD, such as eosinophilic esophagitis; identifying complica-
tions of reflux disease; and evaluating for empirical treatment failure.54wnloaded for Anonymous User (n/a) at Rady Childrens Hospital from ClinicalKey.com/nursing by Elsevier on September 10, 2018.
For personal use only. No other uses without permission. Copyright ©2018. Elsevier Inc. All rights reserved.
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Twenty-four–hour esophageal pH monitoring measures the frequency and duration of
acid esophageal reflux. This test can be performed by either placing a nasal catheter,
or by clipping a wireless sensor to the esophageal mucosa via endoscopy. A decrease
in the intraesophageal pH to less than 4 is considered acidic exposure. For criteria to
diagnose acid reflux, please refer to the North American Society for Pediatric Gastro-
enterology, Hepatology, and Nutrition–European Society for Pediatric Gastroenter-
ology, Hepatology, and Nutrition consensus paper from 2009.19 The main
indications for pH monitoring include evaluating endoscopy-negative patients for
abnormal esophageal acid exposure if they are being considered for antireflux proced-
ures and evaluating patients who are refractory to PPI therapy.55 There are limitations
to standard pH monitoring. It is a poor detector of weakly acidic (pH of 4-7) reflux56
and can also overestimate acid exposure by picking up “pH-only” episodes, in which
there is no reflux.57 In infants and children, weakly acidic GER is more prevalent than in
adults,57,58 which can explain why abnormal esophageal pH monitoring does not
correlate with symptom severity in infants.59 Abnormal esophageal pH is observed
more frequently in adults and children with erosive esophagitis.60,61
MII uses change in impedance to measure the anterograde and retrograde move-
ment of fluid, solids, and air in the esophagus. Dual pH-MII is able to detect reflux
regardless of pH value, detect anterograde versus retrograde flow thereby distinguish-
ing between swallows and GER, determine the height of refluxate, and differentiate
between liquid, gas, or mixed refluxate.62 Nonacid pH is defined as a pH of greater
than 4 and the reflux index is defined as the percentage of time the pH drops to
less than 4. Tables 2 and 3 provide the reflux parameter definitions and normal values
for reflux per 24 hours in infant and children. Normal values for infants and children
with nonacid and acid reflux were determined by Mousa and colleagues63 in a multi-
center study evaluating multiple parameters of reflux via pH/MII in a very clean popu-
lation. The infant and children selected had no evidence of acid reflux or symptoms
associated with regurgitation. They were also off antireflux medications at the time
of the procedure and did not have a fundoplication. Based on the study, in infants,
more than 48 acid reflux episodes or more than 67 nonacid reflux episodes in 24 hours
are considered pathologic. With children, more than 55 acid reflux episodes or more
than 34 nonacid reflux episodes in 24 hours is considered pathologic.
In infants and children, pH-MII optimizes the yield of the GER–symptom associa-
tion.64 Indications for pH-MII include (1) evaluating the efficacy of antireflux therapy,
(2) endoscopy-negative patients with symptoms concerning for reflux despite PPI
therapy in whom documentation of nonacid reflux will alter clinical management,55,62
(3) evaluating tube fed patients for reflux, because the majority of refluxate during tube
feeding is nonacidic,62 and (4) differentiating aerophagia from GER.Motility Testing
Findings on esophageal manometry are not sensitive or specific enough to make the
diagnosis of GERD, but can identify alternate motor disorders that may present similar
to GERD.19,54 Esophageal dysmotility is present in a proportion of patients with
GERD,65 with motor dysfunctions of both the LES and esophageal body being the ma-
jor factors predicting medical refractoriness of reflux disease in children.66 However,
patients with gastroparesis are at increased risk for GERD,67 and there are studies
that show that infants and young children with delayed gastric emptying tend to be
more symptomatic,68 gastric emptying studies do not confirm the diagnosis of
GERD69 and are not recommended for its routine evaluation.ed for Anonymous User (n/a) at Rady Childrens Hospital from ClinicalKey.com/nursing by Elsevier on September 10, 2018.
For personal use only. No other uses without permission. Copyright ©2018. Elsevier Inc. All rights reserved.
Table 2
Reflux parameters on pH-multichannel intraluminal impedance
Definitions
Liquid reflux Drop in impedance of 50% of baseline value with subsequent
recovery, in 2 of the distal-most channels
Acid GER pH decreases and remains <4 for 5 s; if pH was already <4, it
decreases by 1 pH unit for 5 s; with or without a decrease in
impedance of 50% of baseline value
Nonacid GER pH increases, remains unchanged, or decreases by 1 pH unit while
remaining 4, with a retrograde decrease in impedance of 50%
of baseline value in 2 of the distal-most channels
Gas reflux Simultaneous and rapid increases in impedance in 2 channels
(>3000 Ohms) of the distal-most channels
Extent of reflux migration
Localized to distal
esophagus
Height of reflux is confined to the 2 most distal impedance channels
(channels 5 and 6)
Proximal Height of refluxate reaches either or both of the most proximal
channels (channels 1 and/or 2)
Parameters of symptom association
Reflux index Percent of time pH is <4
Symptom index Percent of symptoms episodes that are related to reflux ([no. of
reflux-related symptom episodes O total no. of symptom
episodes]  100)
 Positive when >50%
Symptom sensitivity
index
Percent of symptom associated reflux episodes ([no. of reflux-
related symptom episodes O total no. of reflux episodes]  100)
 positive when >10%
Symptoms associated
probability
Statistical probability that symptoms and GER events are associated
 Positive when >95%
Abbreviation: GER, gastroesophageal reflux.
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Although GERD is reported commonly on upper gastrointestinal studies, the correla-
tion between reflux reported on upper gastrointestinal studies and 24-h pH monitoring
is poor.70,71 Therefore, upper gastrointestinal studies should be reserved for defining
anatomic abnormalities and not reflux.
Diagnostic Trial of Acid Suppression
Because GERD is diagnosed primarily based on symptoms alone in older children
and adolescents, responding to an empirical trial of PPI therapy helps to support,
although it cannot confirm, a diagnosis of GERD.72 In both children73 and adoles-
cent27 patients with endoscopically proven GERD, a 4- to 8-week course of PPI im-
proves symptoms significantly. There are limitations to performing a PPI trial to
diagnose GERD. It does not control for placebo effect, spontaneous resolution of
symptoms, and the possibility that other conditions may improve on PPI treatment.
Additionally, it does not differentiate between healing esophagitis and reflux symp-
toms.54 PPI therapy is more apt to resolve esophagitis than GERD symptoms, so
a negative PPI trial does not exclude GERD as a diagnostic possibility. A trial of
acid suppression in infants and young children is not warranted, because symptoms
suggestive of GERD are less specific.26wnloaded for Anonymous User (n/a) at Rady Childrens Hospital from ClinicalKey.com/nursing by Elsevier on September 10, 2018.
For personal use only. No other uses without permission. Copyright ©2018. Elsevier Inc. All rights reserved.
Table 3
Normal values for acid and nonacid reflux on pH/multichannel intraluminal impedance per 24
hours in infants and children
Infants Children
Median (IQR) 95th Percentile Median (IQR) 95th Percentile
Index of acid regurgitation (%) 0.6 (0.3–0.9) 1.4 0.4 (0.2–0.8) 1.3
No. of acid regurgitation
episodes in 24 h
20 (11–26) 48 14 (11–15) 55
Index of nonacid
regurgitation (%)
0.7 (0.5–1.2) 2.5 0.1 (0–0.3) 1.0
No. of nonacid regurgitation
episodes in 24 h
32 (16–45) 67 6 (3–11) 34
Index of GER episodes (%) 1.4 (0.9–1.2) 2.9 0.6 (0.3–1.2) 2.4
No. of GER episodes in 24 h 54 (33–69) 93 21 (11–41) 71
Abbreviations: GER, gastroesophageal reflux; IQR, interquartile range.
Adapted fromMousaH,MachadoR,OrsiM,etal.Combinedmultichannel intraluminal impedance-
pH (MII-pH): multicenter report of normal values from 117 children. Curr Gastroenterol Rep
2014;16(8):400; andVandenplas Y, Rudolph CD, Di Lorenzo C, et al. Pediatric gastroesophageal reflux
clinicalpracticeguidelines: joint recommendationsof theNorthAmericanSociety forPediatricGastro-
enterology,Hepatology, andNutrition (NASPGHAN) and the European Society for PediatricGastroen-
terology, Hepatology, and Nutrition (ESPGHAN). J Pediatr Gastroenterol Nutr 2009;49(4):498–547.
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DownloadBronchoalveolar Lavage and Pepsin (for Evidence of Microaspiration with Reflux or
Swallowing Disorder)
Evaluating pulmonary aspirates for pepsin has been investigated as a biomarker for
GERD. Although studies support the association of the 2 conditions,74–76 problems
with prior studies include pepsin assays not being specific to pepsin A, the isoform
found exclusively in the stomach.77 Other pepsin isoforms, mainly pepsin C, are
also produced in the lungs, pancreas, and seminal vesicles, thereby limiting speci-
ficity. Prospective studies evaluating children with chronic cough, asthma,78 and
GERD79 have found that lung pepsin does not predict pathologic esophageal reflux,
nor does it correlate with extraesophageal symptoms or quality of life score. Lung
pepsin did, however, correlate with lung inflammation, suggesting a role for pepsin
as a biomarker for reflux-related lung disease.78
TREATMENT
Infant
Infant regurgitation is common and largely physiologic, peaking at 3 to 4 months of age,
and resolving by12 to13months of age.18 In thriving infants inwhomsymptomsof regur-
gitation are likely secondary to physiologic GER, management should focus on parental
education and support.80 For formula-fed infants, reducing feeding volumes in overfed
infants, or offering smaller, more frequent meals, can decrease reflux episodes.19
Changing the infant’s body position while awake can be effective. The prone and left
sidedownpositions are associatedwith fewer reflux episodes,81,82 but shouldbe recom-
mended only in awake infants under the age of 1 to decrease the risk of sudden infant
death syndrome. Thickening feeds helps to reduce the visual symptoms of GER,83,84
although it does not esophageal reflux frequency, as shown by pH monitoring.85,86
PPI use has been increasing steadily in infants with the most common reasons for
use being identified as GER (59%) and poor feeding (23%).87 The mean age of use,
between 4 and 8 months of age, correlates with the timing of physiologic reflux. Theed for Anonymous User (n/a) at Rady Childrens Hospital from ClinicalKey.com/nursing by Elsevier on September 10, 2018.
For personal use only. No other uses without permission. Copyright ©2018. Elsevier Inc. All rights reserved.
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Domajority of infants who are being placed on antireflux drugs do not meet the criteria for
GERD.88 PPIs have not been shown to benefit infant symptoms attributed to GER over
placebo,25,26 and discontinuing antireflux medications in this age group has not shown
to cause a significant difference in symptoms. Therefore, antireflux medications are
not recommended for infants with GER.
Milk protein sensitivity can be difficult to differentiate from GER symptoms with no
diagnostic tools to differentiate between the 2 entities.89 A prospective study found
that 85 of 204 patients with documented GER by pH impedance testing had milk pro-
tein sensitivity.21 Therefore, infants with recurrent vomiting and persistent symptoms
may benefit from a 2- to 4-week trial of an extensively hydrolyzed protein formula.22,90
Children and Adolescents
Lifestyle changes
Recommendations for lifestyle changes are derived from adult data. Although there is
some physiologic evidence that various foods as well as alcohol and tobacco affect
the pressure of the LES, targeted interventions have not shown any benefit in clinical
trials.91,92 Patients should avoid foods and beverages that trigger their personal GERD
symptoms. The only beneficial measures documented are weight loss in obese pa-
tients,93 avoidance of late night eating,94 elevation of the head of the bed, and prone
or left-sided sleeping position.95
Acid suppression
Histamine-2 receptor antagonists Parietal cells secrete acid in response to 3 stimuli:
histamine at the H2 histamine receptor, acetylcholine, and gastrin. Histamine 2 recep-
tor agonists (H2RAs) suppress gastric acid secretion by competitively inhibiting hista-
mine at the parietal cell’s H2 receptor. In adequate doses, H2RAs are effective in the
treatment of peptic disease96 and healing erosive esophagitis compared with pla-
cebo.97,98 However, patients requiring more than occasional use can develop to rapid
tachyphylaxis.99 Dosage requirements vary by age, but children require a relative
higher dose than adults.96
Proton pump inhibitors PPIs are the most potent acid suppressants. They work by
blocking the final step in acid secretion: the gastric H1/K1-adenosine triphosphatase
(ATPase), which causes resorption of K1 ions and secretion of H1 ions. Compared
with H2RAs and placebo, PPIs provide faster and increased relief of symptoms and
are more effective in healing erosive esophagitis.97,100,101 After erosive esophagitis
is healed, there is a low rate of relapse and recurrence of GERD symptoms.102
Thus, prolonged courses of PPI are not recommended without continued diagnosis.
There is increasing evidence of side effects from prolonged acid suppression,
resulting from hypochlorhydria. For this reason, the smallest effective dose of acid
suppression for only the necessary period of time should be used.54 Hypochlorhydria
impairs vitamin B12, calcium, and iron absorption. PPI therapy has been associated
with fractures in adults with osteoporosis, as well as fractures in young adults.103
This same association has not been seen in children younger than 18 years of age.
Long-term acid suppression also has increased infectious risks. In neonates, H2RA
therapy is associated with higher rates of necrotizing enterocolitis.104 Long-term
hypochlorhydria is hypothesized to alter the intraluminal environment, promoting the
growth of small bowel bacteria.105 This leads to small bowel bacterial overgrowth, a
condition in which the bacteria cause excessive fermentation, resulting in symptoms
of bloating, abdominal pain, and diarrhea. The reduction in gastric acid secretion al-
lows pathogen colonization from the upper gastrointestinal tract. In PPI users, a sig-
nificant positive dose–response relationship has been observed between PPI usewnloaded for Anonymous User (n/a) at Rady Childrens Hospital from ClinicalKey.com/nursing by Elsevier on September 10, 2018.
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Downloadand increased risk of community-acquired pneumonia.106,107 There was a similar
increased risk, although no dose–response relationship, seen with H2RA use. With
both PPI and H2RA use, there is an increased risk of gastroenteritis107 as well as
community-acquired Clostridium difficile infection.108 Gastric polyps and nodules
can be noted after prolonged PPI therapy, but these changes are benign.54
Antacids Antacids are compounds containing different combinations, such as calcium
carbonate, sodium bicarbonate, aluminum, and magnesium hydroxide. They provide
rapid but short-term symptom relief by buffering gastric acid, and in high doses are
as effective as H2RAs.109,110 These drugs have no efficacy in healing erosive esopha-
gitis.111 Dosing of these medications is based on age and weight (Table 4).
SURGICAL MANAGEMENT
Fundoplication is an antireflux surgery that may benefit children with confirmed GERD
who have failed optimal medical therapy, who are dependent on medical therapy over
a long period of time, or who have life-threatening complications of GERD.19 Although
studies are needed to confirm which cohort of GERD patients are most likely to benefit
from a fundoplication, it is suggested for those with respiratory complications,
including asthma or recurrent aspiration related to GERD.
Despite its value in preventing GERD, fundoplication has other consequences
including gas bloat syndrome, impaired gastric accommodation, gastric hypersensi-
tivity, rapid gastric emptying, retching, or dysphagia.112 Children with neurologicTable 4
Pharmacologic agents for the treatment of gastroesophageal reflux disease
Medication Dose Age
Proton pump inhibitors
Omeprazole 0.7–3.3 mg/kg/d, max 20 mg/d 2 y
Lansoprazole 0.7–3 mg/kg/d 1 y
Esomeprazole <20 kg: 10 mg/d
20 kg: 10-20 mg/d
1 y
Pantoprazole 15 kg to <40 kg: 20 mg/d
40 kg: 40 mg/d
Pediatric indication for erosive
esophagitis in 5 y
Histamine-2 receptor antagonists
Famotidine 1 mg/kg/d divided in 2–3 doses,
max 20 mg bid
1 mo
Ranitidine 5–10 mg/kg/d divided in 2–3 doses,
max 300 mg/d
1 mo
Cimetidine 400 mg 4/d No pediatric indication
Antacids
Calcium
carbonate
2–5 yo: 375–400 mg PRN; max
1500 mg/d
6–11 yo: 750–800 mg PRN; max
3000 mg/d
12 yo: 500–3,000 mg PRN; max
7500 mg/d
2 y
Sucralfate No pediatric indication for
independent treatment of
gastroesophageal reflux disease
Abbreviations: max, maximum; PRN, as needed; yo, years old.
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Doimpairments suffer from many conditions, such as scoliosis and epilepsy, which
decrease the success rate of antireflux therapy. In this group of children, fundoplica-
tion is associated with an high recurrence rate and significant morbidity and mortality,
with a 40% surgical failure rate, 12% to 30% rate of recurrent reflux, 59% experiencing
postoperative complications, and a 1% to 3% mortality rate. Surgery done in early in-
fancy also has a higher failure rate and greater risk for surgical mortality.113
Transpyloric feeds have been proposed as an alternative to fundoplication in pa-
tients with GERDwho are medically complex. Reflux can still occur during transpyloric
feeds, and is thought to be a result of increased transient LES relaxations when fat is
instilled into the small bowel.114 Despite this phenomenon, the number of reflux events
and the percentage of full-column events during transpyloric feeds are lower when
compared with gastric feeds. Studies comparing transpyloric feeds and fundoplica-
tion are few, but suggest that there is a trend toward more major complications with
fundoplication compared with gastrojejunal feeds in neurologically impaired chil-
dren.115 The 2 therapies have comparable rates in decreasing aspiration pneumonia,
although neither eliminates the risk completely.116
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